Live feed
·
INSIDERFiling
Krystal Biotech Inc. logo

President, R&D Krishnan Suma converted options into 67,225 shares and covered exercise/tax liability with 30,584 shares, increasing direct ownership by 1% to 1,428,155 units (SEC Form 4)